Investors are always looking for stocks that are poised to beat at earnings season and Kezar Life Sciences, Inc. KZR may be one such company. The firm has earnings coming up pretty soon, and events ...

KZR is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of KZR shares has increased $0.01 since the market last closed. This is a 0.25% ...

Kezar Life Sciences, Inc. KZR, an early-to-mid clinical-stage company, announced initiating a strategic restructuring program to focus on its clinical-stage studies, which is expected to fuel ...

The latest price target for Kezar Life Sciences (NASDAQ:KZR) was reported by Wells Fargo on December 19, 2024. The analyst firm set a price target for $9.00 expecting KZR to rise to within 12 months ...

Kezar Life Sciences, Inc. (NASDAQ:KZR) shares are soaring Tuesday following a positive clinical readout. What Happened: California-based Kezar announced positive interim results from the Phase 2 ...

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the ...